Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Singapore's main stock market index, the STI, fell to 4329 points on October 17, 2025, losing 0.63% from the previous session. Over the past month, the index has climbed 0.38% and is up 18.92% compared to the same time last year, according to trading on a contract for difference (CFD) that tracks this benchmark index from Singapore. Singapore Stock Market (STI) - values, historical data, forecasts and news - updated on October of 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Prices for FTSE Straits Times Index including live quotes, historical charts and news. FTSE Straits Times Index was last updated by Trading Economics this September 18 of 2025.
Facebook
Twitterhttps://www.transparencymarketresearch.com/privacy-policy.htmlhttps://www.transparencymarketresearch.com/privacy-policy.html
Sexually Transmitted Diseases (STD) Diagnostics Market Introduction
| Attribute | Detail |
|---|---|
| Driver |
|
Regional Outlook of Sexually Transmitted Diseases (STD) Diagnostics Industry
| Attribute | Detail |
|---|---|
| Leading Region | North America |
Sexually Transmitted Diseases (STD) Diagnostics Market Snapshot
| Attribute | Detail |
|---|---|
| Market Value in 2023 | US$ 7.1 Bn |
| Forecast (Value) in 2034 | US$ 15.9 Bn |
| Growth Rate (CAGR) | 7.6% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IntroductionSexually transmitted infections (STI) are highly prevalent among women of reproductive age (WRA) and increase the risk of HIV acquisition and transmission. However, the burden of extragenital STIs is understudied among WRA in the US. Estimates of disease are urgently needed among women living with (WWH) and without HIV (WWOH), to inform sex-specific screening guidelines.MethodsCross-sectional data from cisgender WWH and WWOH, ages 18–45 years, enrolled in the Study of Treatment and Reproductive Outcomes (STAR) from March 2021 to August 2023 at six Southern US sites was analyzed. Sociodemographic and behavioral assessments were performed using structured interviewer-administered questionnaires. Nucleic-acid amplification tests were performed, regardless of symptoms, on self-collected urine, rectal, and pharyngeal swabs to detect trichomoniasis, chlamydia, and gonorrhea. Sociodemographic characteristics and risk factors were compared by STI status and concordance between genital and extragenital STIs was examined.ResultsAmong the 543 participants, 55.2% WWH, mean age was 34.0 (SD ± 7.14) years old, most (72.5%) were non-Hispanic Black, 41.6% had multiple sexual partners, and 85.6% engaged in unprotected sex. Overall, 1.9% tested positive for genital chlamydia, 2.9% rectal chlamydia, 0.6% oropharyngeal chlamydia, 3.4% genital gonorrhea, 1.2% rectal gonorrhea, 1.3% oropharyngeal gonorrhea, and 12.2% trichomoniasis. Genital chlamydia was associated with rectal chlamydia (p < 0.001) but not oropharyngeal chlamydia; and genital gonorrhea associated with rectal (p < 0.001) and oropharyngeal (p = 0.0011) gonorrhea. Eight (11.1%) pregnant participants were diagnosed with at least one STI. Higher genital chlamydia risk was associated with women without healthcare provider visits in the past year [RR = 7.14, 95% CI (1.92, 25.00); p = 0.043]; while higher trichomoniasis risk was associated with lower educational attainment of high school or below [RR = 2.94, 95% CI (1.49, 5.88); p = 0.009] and an average monthly income of less than $1,500 USD [RR = 4.76, 95% CI (1.82, 12.5); p = 0.011]. HIV-status was not associated with genital or extragenital STIs.DiscussionPrevalence of genital, rectal, oral chlamydia (1.8%, 2.8%, and 0.6%) and gonorrhea (3.3%, 1.1%, and 1.3%), and genital trichomoniasis (11.4%) are high among WRA with and without HIV. The adverse impact for women’s reproductive health and HIV transmission highlights the importance of extragenital STI testing for women in areas of high prevalence of STIs in the US.
Facebook
TwitterOpen Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
Table 6.1 lists the rates of Sexually Transmitted Infections (STI) for the most recent three-fiscal-year periods available, for the local geographic area and Alberta. This table is part of "Alberta Health Primary Health Care - Community Profiles" report published March 2019.
Facebook
Twitterhttps://wemarketresearch.com/privacy-policyhttps://wemarketresearch.com/privacy-policy
The STD Diagnostics Market is set to grow from USD 7.8 Billion in 2025 to USD 18.6 Billion by 2035, driven by rising awareness, at an 8.2% CAGR.
| Report Attribute | Description |
|---|---|
| Market Size in 2025 | USD 7.8 Billion |
| Market Forecast by 2035 | USD 18.6 Billion |
| CAGR % 2025-2035 | 8.2% |
| Base Year | 2024 |
| Historic Data | 2020-2024 |
| Forecast Period | 2025-2035 |
| Report USP | Production, Consumption, company share, company heatmap, company production capacity, growth factors and more |
| Segments Covered | By Product, By Test Type, By Disease Type, By Technology, By End-user |
| Regional Scope | North America, Europe, APAC, Latin America, Middle East and Africa |
| Country Scope | U.S., Canada, U.K., Germany, France, Italy, Spain, Benelux, Nordic Countries, Russia, China, India, Japan, South Korea, Australia, Indonesia, Thailand, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Egypt, South Africa, Nigeria |
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Key information about Singapore FTSE Strait Times
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Table 2 notes: Data shown are shown for the total population eligible for HIV testing on 01 June 2003 who participated in the sexual behavior surveys (n = 5,901 men and n = 11,293 women.) For continuous variables, two-sided differences in distributions of characteristics between migrants and non-migrants, in men and in women, tested with the Wilcoxon rank sum test. For categorical variables, the chi-square test was used (excluding ‘missing’ category).aMigration in Table 2 defined as at least one change of residence as an individual (in-migration, out-migration or internal migration) in the two years prior to the HIV test or eligibility date (June 1, 2003) for individuals who did not participate in testing.bRespondent agrees with either of the following questions: “is there anything that happened to you in the past that may have put you at risk of becoming infected with HIV?” or “are you currently in a situation where you may be at risk of becoming infected with HIV?”.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IntroductionDespite progress in controlling HIV/AIDS and STIs, these health challenges persist, with 39.9 million people living with HIV in 2023 and more than 350 million affected by STIs annually. Thailand is a major migrant hub in Southeast Asia. This study investigated the factors influencing preventive behaviors related to HIV/AIDS and STIs among Myanmar migrants in Chiang Mai province, Thailand.MethodsA cross-sectional study was conducted in 2023 among 424 Myanmar migrants aged 18–45 years. Participants were selected through convenience sampling from a local hospital and community gathering locations in Chiang Mai province. Multiple logistic regression analysis was used to identify factors influencing preventive behaviors.ResultsThe participants’ average age was 29.92 years; 56.8% were married, and 67.5% had completed primary or lower education. The average monthly income was
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 3,200(USD Million) |
| MARKET SIZE 2025 | 3,300(USD Million) |
| MARKET SIZE 2035 | 4,500(USD Million) |
| SEGMENTS COVERED | Diagnosis Method, Pathogen Type, End User, Sample Type, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | rising STD prevalence, increasing awareness programs, technological advancements in diagnostics, supportive government initiatives, growing demand for point-of-care testing |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | DiaSorin, Diagnostics Biochem Canada, Ortho Clinical Diagnostics, BioRad Laboratories, Avantor, Roche, Cepheid, Hologic, Siemens Healthineers, Meridian Bioscience, Abbott, Thermo Fisher Scientific, Becton Dickinson, Fujirebio, Grifols |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Rapid point-of-care testing innovations, Increased awareness and education campaigns, Integration of AI for diagnostics, Expansion in telehealth services, Growing demand for at-home testing solutions |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.2% (2025 - 2035) |
Facebook
Twitterhttps://www.techsciresearch.com/privacy-policy.aspxhttps://www.techsciresearch.com/privacy-policy.aspx
Canada Sexually Transmitted Disease Testing Market has valued at USD 319.1 Million in 2023 and is expected to reach USD 413.8 Million by 2029 with a CAGR of 4.43% during the forecast period.
| Pages | 86 |
| Market Size | 2023: USD 319.1 Million |
| Forecast Market Size | 2029: USD 413.8 Million |
| CAGR | 2024-2029: 4.43% |
| Fastest Growing Segment | Reagents & Kits |
| Largest Market | Ontario |
| Key Players | 1. F. Hoffmann-La Roche Ltd 2. Abbott Laboratories 3. Becton, Dickinson and Company 4. Hologic, Inc. 5. Cepheid 6. Thermo Fisher Scientific Inc. 7. bioMérieux 8. Bio-Rad Laboratories, Inc. 9. DiaSorin S.p.A. 10. Seegene, Inc. |
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Socio-demographic characteristics of HIV positive women at PMTCT in the hospital of Eastern Amhara, Ethiopia 2020.
Facebook
Twitterhttps://www.techsciresearch.com/privacy-policy.aspxhttps://www.techsciresearch.com/privacy-policy.aspx
Global Sexually Transmitted Diseases (STD) Diagnostics Market was valued at USD 90.75 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.54% through 2029.
| Pages | 180 |
| Market Size | USD 90.75 Billion |
| Forecast Market Size | USD 132.14 Billion |
| CAGR | 6.54% |
| Fastest Growing Segment | Instruments and Service |
| Largest Market | North America |
| Key Players | 1. Becton Dickinson and Company 2. F. Hoffmann-La Roche Ltd. 3. Hologic, Inc. 4. bioMérieux SA 5. Abbott Laboratories Inc. 6. Danaher Corporation 7. Qiagen N.V. 8. Thermo Fisher Scientific Inc. 9. DiaSorin S.p.A 10. Bio-Rad Laboratories, Inc. |
Facebook
TwitterMIT Licensehttps://opensource.org/licenses/MIT
License information was derived automatically
Protein-Protein, Genetic, and Chemical Interactions for STI (Arabidopsis thaliana (Columbia)) curated by BioGRID (https://thebiogrid.org); DEFINITION: protein STICHEL
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Prices for STI - 股票价格 including live quotes, historical charts and news. STI - 股票价格 was last updated by Trading Economics this September 28 of 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Prices for STI - 株価 including live quotes, historical charts and news. STI - 株価 was last updated by Trading Economics this October 1 of 2025.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
ObjectivesTrichomoniasis one of the most neglected sexually transmitted diseases (STDs), imposes a significant global disease burden. This study aims to assess the burden and trends of trichomoniasis from 1990 to 2021 and to project its incidence from 2022 to 2050.MethodsThis study utilized data from the Global Burden of Disease 2021 study for secondary analysis. We determined the age-standardized incidence rate (ASIR) and disability-adjusted life years (DALYs) of trichomoniasis by sex, age, and socio-demographic index (SDI) level. Changes in burden trends across sex and age were explored from 1990 to 2021, using joinpoint regression. The incidence of trichomoniasis was projected for the period 2022 to 2050, using R software.ResultsFrom 1990 to 2021, the estimated annual percentage change (EAPC) in the global ASIR of trichomoniasis was 0.09 (95% CI: 0.06 to 0.13). In 2021, the global ASIR of trichomoniasis was 4,133.41 per 100,000 people (95% UI: 3,111.37 to 5,583.56 per 100,000). By population group, the ASIR was higher in men (4,353.43 per 100,000) than in women (3,921.31 per 100,000) in 2021, while the DALY rate was significantly higher in women than in men (6.45 vs. 0.23 per 100,000). When divided by age groups, the trend in ASIR among women aged 30–54 years aligned closely with the overall population incidence trend. In 2021, ASIRs were highest in low SDI regions, and the projected ASIRs by 2050 are 5,680.57 per 100,000 in males and 5,749.47 per 100,000 in females.ConclusionTrichomoniasis represents a significant global disease burden, particularly among women in low-income areas and individuals aged 30–54 years. The study highlights the need for targeted strategies to reduce the burden of trichomoniasis-related infections, especially in vulnerable populations.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Prices for STI - Биржевая Цена including live quotes, historical charts and news. STI - Биржевая Цена was last updated by Trading Economics this September 26 of 2025.
Facebook
Twitterhttps://www.shibatadb.com/license/data/proprietary/v1.0/license.txthttps://www.shibatadb.com/license/data/proprietary/v1.0/license.txt
Network of 46 papers and 117 citation links related to "STI Vaccines: Status of Development, Potential Impact, and Important Factors for Implementation".
Facebook
Twitterhttps://www.shibatadb.com/license/data/proprietary/v1.0/license.txthttps://www.shibatadb.com/license/data/proprietary/v1.0/license.txt
Network of 45 papers and 66 citation links related to "Moderno Love: Sexual Role-Based Identities and HIV/STI Prevention Among Men Who Have Sex with Men in Lima, Peru".
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Singapore's main stock market index, the STI, fell to 4329 points on October 17, 2025, losing 0.63% from the previous session. Over the past month, the index has climbed 0.38% and is up 18.92% compared to the same time last year, according to trading on a contract for difference (CFD) that tracks this benchmark index from Singapore. Singapore Stock Market (STI) - values, historical data, forecasts and news - updated on October of 2025.